SGRY

Surgery Partners, Inc. [SGRY] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

SGRY Stock Summary

Top 10 Correlated ETFs

SGRY


Top 10 Correlated Stocks

SGRY


In the News

01:01 29 Mar 2024 SGRY

Surgery Partners (SGRY) Upgraded to Buy: What Does It Mean for the Stock?

Surgery Partners (SGRY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

10:56 29 Mar 2024 SGRY

Wall Street Analysts Believe Surgery Partners (SGRY) Could Rally 39.04%: Here's is How to Trade

The mean of analysts' price targets for Surgery Partners (SGRY) points to a 39% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

11:26 29 Mar 2024 SGRY

Warren Buffett's Annual Letter: Key Insights for Investors

Follow Warren Buffett's latest tips and bet on top-ranked stocks like Microsoft (MSFT), Amazon.com (AMZN), Surgery Partners (SGRY) and Nvidia (NVDA).

10:31 29 Mar 2024 SGRY

Here's What Key Metrics Tell Us About Surgery Partners (SGRY) Q4 Earnings

While the top- and bottom-line numbers for Surgery Partners (SGRY) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

09:41 29 Mar 2024 SGRY

Surgery Partners (SGRY) Beats Q4 Earnings Estimates

Surgery Partners (SGRY) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.27 per share a year ago.

10:20 29 Mar 2024 SGRY

Gear Up for Surgery Partners (SGRY) Q4 Earnings: Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Surgery Partners (SGRY) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

04:05 29 Mar 2024 SGRY

Surgery Partners, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call Details

BRENTWOOD, Tenn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2023 results before the market opens on Monday, February 26, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time)

01:11 29 Mar 2024 SGRY

Why Surgery Partners (SGRY) is Poised to Beat Earnings Estimates Again

Surgery Partners (SGRY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

07:48 29 Mar 2024 SGRY

Surgery Partners feeling no pinch from macroeconomic weakness

Surgery Partners Inc. NASDAQ: SGRY is a leading healthcare services provider that owns and operates over 180 outpatient surgical centers in 31 states. Its integrated delivery model includes surgical facilities and ancillary services comprised of anesthesia services and multi-specialty physician groups.

01:40 29 Mar 2024 SGRY

Surgery Partners, Inc. to Present at Upcoming Investor Conference

BRENTWOOD, Tenn., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced that Eric Evans, Chief Executive Officer and Dave Doherty, Chief Financial Officer will meet with investors at the J.P. Morgan Healthcare Conference, including a presentation on Monday, January 8, 2024 at 5:15p.m. (Eastern Time).

SGRY Financial details

Company Rating
Neutral
Market Cap
3.52B
Income
55M
Revenue
2.74B
Book val./share
15.8
Cash/share
1.56
Dividend
-
Dividend %
-
Employees
10.5K
Optionable
No
Shortable
Yes
Earnings
29 Apr 2024
P/E
52.77
Forward P/E
25.94
PEG
-9.86
P/S
1.55
P/B
2.09
P/C
19.12
P/FCF
28.7
Quick Ratio
1.39
Current Ratio
1.75
Debt / Equity
1.08
LT Debt / Equity
0.6
-
-
EPS (TTM)
0.44
EPS next Y
1.15
EPS next Q
0.26
EPS this Y
-109.97%
EPS next Y
160.41%
EPS next 5Y
313.27%
EPS last 5Y
NAN%
Revenue last 5Y
8.42%
Revenue Q/Q
9.09%
EPS Q/Q
-102.76%
-
-
-
-
SMA20
-10.75%
SMA50
-11.72%
SMA100
22.94%
Inst Own
50.3%
Inst Trans
0.48%
ROA
1%
ROE
4%
ROC
0.06%
Gross Margin
24%
Oper. Margin
14%
Profit Margin
3%
Payout
-
Shs Outstand
126.61M
Shs Float
73.01M
-
-
-
-
Target Price
64
52W Range
22.05-45.79
52W High
-33.71%
52W Low
+35.59%
RSI
50.19
Rel Volume
0.81
Avg Volume
919.27K
Volume
743.92K
Perf Week
7.69%
Perf Month
-12.91%
Perf Quarter
9.63%
Perf Half Y
2.83%
-
-
-
-
Beta
2.719
-
-
Volatility
0.78%, 1.97%
Prev Close
-0.37%
Price
29.83
Change
0.64%

SGRY Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
37.9338.1430.7227.6221.84
Net income per share
0.950.030.980.95-0.09
Operating cash flow per share
2.685.061.21.732.34
Free cash flow per share
1.164.180.410.851.63
Cash per share
1.926.525.383.081.56
Book value per share
6.172.3715.0421.7315.82
Tangible book value per share
-71.45-72.06-54.61-45.45-8.11
Share holders equity per share
6.172.3715.0421.7315.82
Interest debt per share
63.7969.6848.5434.4218.88
Market cap
755.82M1.41B3.87B2.56B4.02B
Enterprise value
3.56B4.29B6.77B5.21B6.88B
P/E ratio
16.41.09K54.7129.45-337.68
Price to sales ratio
0.410.761.741.011.46
POCF ratio
5.845.7344.4116.1313.68
PFCF ratio
13.526.94131.1332.7619.6
P/B Ratio
2.5412.243.551.282.02
PTB ratio
2.5412.243.551.282.02
EV to sales
1.952.313.042.052.51
Enterprise value over EBITDA
10.3512.5814.9810.3313.07
EV to operating cash flow
27.5217.3977.7632.823.43
EV to free cash flow
63.7621.05229.5966.6133.58
Earnings yield
0.0600.020.030
Free cash flow yield
0.070.140.010.030.05
Debt to equity
9.7427.653.031.471.08
Debt to assets
0.580.590.540.440.31
Net debt to EBITDA
8.158.436.425.255.44
Current ratio
1.321.441.761.871.71
Interest coverage
1.321.221.371.471.79
Income quality
2.87189.921.231.83-24.69
Dividend Yield
00000
Payout ratio
000.0700
Sales general and administrative to revenue
0.050.050.050.040.04
Research and developement to revenue
00000
Intangibles to total assets
0.690.650.650.630.62
Capex to operating cash flow
-0.57-0.17-0.66-0.51-0.3
Capex to revenue
-0.04-0.02-0.03-0.03-0.03
Capex to depreciation
-0.96-0.45-0.58-0.7-0.75
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
11.511.1918.1721.515.81
ROIC
0.0600.060.050.08
Return on tangible assets
0.0300.030.030
Graham Net
-96.49-98.01-74.21-65.48-24.19
Working capital
127.9M244.7M409.3M427.6M372M
Tangible asset value
-3.45B-3.51B-3.96B-4.18B-1.02B
Net current asset value
-4.49B-4.61B-5.17B-5.76B-2.76B
Invested capital
9.7427.653.031.471.08
Average receivables
317.27M354.55M406.2M443.25M484.95M
Average payables
90M98.45M112.55M138.25M164.3M
Average inventory
44.83M51.35M58.75M66.25M73.3M
Days sales outstanding
65.157570.5765.5968.34
Days payables outstanding
25.0724.7126.328.1729.18
Days of inventory on hand
12.0113.9112.8613.2712.4
Receivables turnover
5.64.875.175.565.34
Payables turnover
14.5614.7713.8812.9612.51
Inventory turnover
30.426.2528.3727.5129.44
ROE
0.150.010.060.04-0.01
Capex per share
-1.52-0.88-0.8-0.88-0.71

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
75.355.315.55.85
Net income per share
0.230.010.150.29-0.01
Operating cash flow per share
0.070.60.410.850.5
Free cash flow per share
-0.150.40.210.70.34
Cash per share
2.81.971.411.931.56
Book value per share
19.7715.7616.0516.3615.8
Tangible book value per share
-41.3515.1-12.86-35.11-8.1
Share holders equity per share
19.7715.7616.0516.3615.8
Interest debt per share
29.5923.3720.8223.6217.53
Market cap
2.82B4.29B5.66B3.58B4.02B
Enterprise value
5.46B6.91B8.05B6.29B6.89B
P/E ratio
30.21894.0774.8224.95-1.01K
Price to sales ratio
3.986.448.475.325.47
POCF ratio
391.157.6108.5634.2664.27
PFCF ratio
-181.6785.49215.0641.8194.01
P/B Ratio
1.412.192.81.792.02
PTB ratio
1.412.192.81.792.02
EV to sales
7.7310.3712.069.339.37
Enterprise value over EBITDA
32.1765.1163.52528.639.89
EV to operating cash flow
758.7192.73154.4860.14110.05
EV to free cash flow
-352.43137.62306.0173.4160.96
Earnings yield
0.01000.010
Free cash flow yield
-0.010.0100.020.01
Debt to equity
1.471.461.271.471.08
Debt to assets
0.440.430.390.430.31
Net debt to EBITDA
15.5924.6718.88227.516.59
Current ratio
1.871.831.771.751.71
Interest coverage
2.31.552.05-1.662.36
Income quality
0.31-2.85-5.9218.03-62.6
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.040.050.050.160.03
Research and developement to revenue
00000
Intangibles to total assets
0.630.640.650.630.62
Capex to operating cash flow
-3.15-0.33-0.5-0.18-0.32
Capex to revenue
-0.03-0.04-0.04-0.03-0.03
Capex to depreciation
-0.77-0.72-1.06-0.65-0.64
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
10.131.857.3710.391.68
ROIC
0.02-0.040.020.020.02
Return on tangible assets
0.0100.010.010
Graham Net
-59.571.17-27.01-50.3-24.16
Working capital
427.6M393.8M351.6M374.8M372M
Tangible asset value
-4.18B1.92B-1.62B-4.3B-1.02B
Net current asset value
-5.76B393.8M-3.14B-5.9B-2.76B
Invested capital
1.471.461.271.471.08
Average receivables
439.3M454.6M451.4M456.35M488.2M
Average payables
145M148M137.95M140.15M162.9M
Average inventory
70M71.6M71.05M69.85M72.3M
Days sales outstanding
58.0861.1860.6561.7962.86
Days payables outstanding
26.124.4223.0526.3527.81
Days of inventory on hand
12.2912.1412.3212.2911.81
Receivables turnover
1.551.471.481.461.43
Payables turnover
3.453.693.93.423.24
Inventory turnover
7.327.417.37.327.62
ROE
0.0100.010.020
Capex per share
-0.22-0.2-0.21-0.15-0.16

SGRY Frequently Asked Questions

What is Surgery Partners, Inc. stock symbol ?

Surgery Partners, Inc. is a US stock , located in Brentwood of Tn and trading under the symbol SGRY

Is Surgery Partners, Inc. buy or a sell ?

1 stock analysts have 1 predictions with a medium analyst target price of $64. The lowest prediction is $64 and the highest is $64

What is SGRY stock prediction ?

What is Surgery Partners, Inc. stock quote today ?

Surgery Partners, Inc. stock price is $29.83 today.

Is Surgery Partners, Inc. stock public?

Yes, Surgery Partners, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap